Recent Publications and Presentations from the team at the OCD & Anxiety Program of Southern California focusing on ways to enhance treatment efficacy and international dissemination of treatments.

Presentations

• Dr. Björgvinsson will be participating in a Symposia titled, “Understanding and Enhancing the Immediate and Long Term Effects of cognitive behavioral therapy for OCD” at the 2024 Anxiety and Depression Association of America (ADAA) Annual Conference to be held April 11-14, 2024, in Boston, MA.
• Dr. Björgvinsson and Dr. Hansen will be presenting a State-of-the-Art Clinician Session titled, “The Status of International Dissemination of the Bergen 4-Day OCD Treatment: Key Elements of Effective Implementation of the Treatment” at the 2024 Anxiety and Depression Association of America (ADAA) Annual Conference to be held April 11-14, 2024, in Boston, MA.

Publications

• Lee, E., Wetterneck, C., McIngvale, E., Williams, M., & Björgvinsson, T. (in press). Rethinking unacceptable thoughts: Validation of an expanded version of the dimensional obsessive-compulsive scale (DOCS). Behavior Therapy.
• Godfrey, A., Heinrich, A., McIngvale, E., Sy, J., Wheaton, M., & Björgvinsson, T. (in press). Improvement in Distress Tolerance as a mechanism of symptom reduction during intensive exposure and response prevention based treatment for OCD. Behavior Therapy.
• Kvale, G., Hansen, B., Björgvinsson, T., Børtveit, T., Hagen, K., Haseth, S., Beate Kristensen, U., Launes, G., Ressler, K. J., Solem, S., Strand, A., van den Heuvel, O. A., & Öst, L. G. (2018). Successfully treating 90 patients with Obsessive Compulsive Disorder in eight days: The Bergen 4-day treatment. BMC Psychiatry, 18, 1-9.
• Davíðsdóttir, S., Sigurjónsdóttir, Ó., Ludvigsdóttir, S., Hansen, B., Laukvik, I., Hagen, K., Björgvinsson, T., & Kvale G. (2019). Implementation of the Bergen 4-day treatment for obsessive compulsive disorder in Iceland. Clinical Neuropsychiatry, 16, 33-38.
• Klein, K., Harris, E., Björgvinsson, T., & Kertz S. (2020). A network analysis of symptoms of Obsessive Compulsive Disorder and Depression in a clinical sample. Journal of Obsessive-Compulsive and Related Disorders, 27(2), 100556. doi: 10.1016/j.jocrd.2020.100556
• Wetterneck, C., Rouleau, T., Williams, M., Valley, A., La Torre, J., & Björgvinsson, T. (2021). A New Scrupulosity Scale for the Dimensional Obsessive-Compulsive Scale (DOCS): validation with clinical and non-clinical samples. Behavior Therapy, 52(6), 1449-1463. doi: 10.1016/j.beth.2021.04.001
• Wheaton, M., Ward, H., Silber, A., McIngvale, E., & Björgvinsson, T. (2021). How is the COVID-19 pandemic affecting individuals with obsessive-compulsive disorder (OCD) symptoms? Journal of Anxiety Disorders, 81, 102410. doi:10.1016/j.janxdis.2021.102410
• Snorrason, I., Keuthen, N., Lee, H-J., Beard, C., & Björgvinsson, T. (2022). Skin picking scale-revised: diagnostic accuracy and optimal cut-off scores in the university and psychiatry settings. Journal of Obsessive-Compulsive and Related Disorders, 34(9), 100743. doi:10.1016/j.jocrd.2022.100743
• Wheaton, M., McIngvale, E., Van Meter, A., & Björgvinsson, T. (2023). Quality of the therapeutic working alliance as a factor in intensive residential treatment of obsessive-compulsive disorder. Psychiatry Research, 33(4), 442-454. doi: 10.1080/10503307.2022.2138618
• Hjelle, K., Eide, T., Thorsen, A., Kvale, G., Hagen, K., Snorrason, I., Björgvinsson, T., & Hansen B. (2023). The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities. BMC Psychiatry, 23, 570. doi.org/10.1186/s12888-023-05062-7